Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito

BMC GASTROENTEROLOGY Volume 14 published_at 2014-07-2
アクセス数 : 1306
ダウンロード数 : 0

今月のアクセス数 : 50
今月のダウンロード数 : 0
Title
Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito
Creator
Sakata Yasuhisa
Tominaga Kazunari
Kato Mototsugu
Takeda Hiroshi
Shimoyama Yasuyuki
Takeuchi Toshihisa
Iwakiri Ryuichi
Furuta Kenji
Sakurai Kouichi
Odaka Takeo
Kusunoki Hiroaki
Nagahara Akihito
Iwakiri Katsuhiko
Furuta Takahisa
Murakami Kazunari
Miwa Hiroto
Haruma Ken
Takahashi Shin'ichi
Watanabe Sumio
Higuchi Kazuhide
Fujimoto Kazuma
Kusano Motoyasu
Arakawa Tetsuo
Source Title
BMC GASTROENTEROLOGY
Volume 14
Journal Identifire
ISSN 1471-230X
Subjects
Gastroesophageal reflux; Acid-related dysmotility; Postprandial; Herbal medicine; Elderly patient ( Other)
Language
eng
Resource Type journal article
Publisher
BMC
Date of Issued 2014-07-2
Access Rights metadata only access
Relation
[DOI] 10.1186/1471-230X-14-116
[PMID] 24990161
Remark Some authors have received research grants, respectively: Mototsugu Kato from Otsuka Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co., Ltd., AstraZeneca KK., Ltd., Astellas Pharma Inc., and Daiichi-Sankyo Co., Ltd.; Hiroshi Takeda from Tsumura & Co. Ltd., Eiji Umegaki from Takeda Pharmaceutical Co., Ltd.; Akihito Nagahara from Daiichi-Sankyo Co., Ltd.; Katsuhiko Iwakiri from Takeda Pharmaceutical Co.; Yoshikazu Kinoshita has served in speaking and teaching commitments for AstraZeneca KK, Takeda Pharmaceutical Co., Ltd., Astellas Pharma Inc., Eisai Co., Ltd., Taiho Pharmaceutical Co., Ltd., Daiichi-Sankyo, and MSD; ST from Eisai Co., Ltd.; Sumio Watanabe from AstraZeneca Inc., Eisai Co., Ltd., and Takeda Pharmaceutical Co., Ltd.; Kazuhide Higuchi from AstraZeneca KK, Otsuka Pharmaceutical Co. Ltd., Eisai Co., Ltd., Daiichi-Sankyo Co. Ltd., and Nippon-Shinyaku Co. Ltd.; Motoyasu Kusano from Eisai Co., Ltd.; Kazuma Fujimoto from Eisai Co., Ltd., AstraZeneca KK., and Daiichi-Sankyo Co. Ltd.; Tetsuo Arakawa from Eisai Co., Ltd., Daiichi-Sankyo Co. Ltd., and Otsuka Pharmaceutical Co., Ltd. The Center for Clinical Research at Hamamatsu University School of Medicine has received grants from Takeda Pharmaceutical Co., Ltd., AstraZeneca KK, Eisai Co., Ltd., and Daiichi-Sankyo Co. Ltd., and Takahisa Furuta has received lecture fees from those companies. The Division of Upper Gastroenterology, Department of Internal Medicine at Hyogo College of Medicine has received grants from AstraZeneca KK, Astellas Pharma Inc., Otsuka Pharmaceutical Co. Ltd., Eisai Co., Ltd., Tsumura & Co. Ltd., Dainippon Sumitomo Pharma Co. Ltd., Yakult Co. Ltd., and Takeda Pharmaceutical Co., Ltd. The following people have nothing to declare: Yasuhisa Sakata, Kazunari Tominaga, Yasuyuki Shimoyama, Ryuichi Iwakiri, Kenji Furuta, Koichi Sakurai, Takeo Odaka, Hiroaki Kusunoki, Kazunari Murakami, and Ken Haruma. Financial support for this study was provided by the Waksman Foundation of Japan INC.